ACTINIUM PHARMACEUTICALS, INC. Operating Leases, Future Minimum Payments, Due in Two Years
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Operating Leases, Future Minimum Payments, Due in Two Years of $431.96 thousand as of 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-03-15
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $431.96K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $419.90K.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $431.59K.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $405.42K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $431.96K 10-K · filed 2019-03-15 |
| 2017-12-31 | $419.90K 10-K · filed 2018-03-16 |
| 2017-09-30 | $431.59K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $405.42K 10-Q · filed 2017-08-04 |
| 2016-12-31 | $199.44K 10-K · filed 2017-03-16 |
| 2016-09-30 | $199.44K 10-Q · filed 2016-10-28 |
| 2016-06-30 | $199.44K 10-Q · filed 2016-07-29 |
| 2016-03-31 | $199.44K 10-Q · filed 2016-05-10 |
| 2015-06-30 | $28.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $56.01K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $84.01K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |